App Description>>> INTRODUCTORY PRICING FOR A LIMITED PERIOD <<<
COPDfastÂ® CalcKitâ„˘ offers our unique respiratory calculators (FEVcalcâ„˘, PYcalcâ„˘ and COPDfastÂ® Lite) into a single bundle.
CalcKitâ„˘ allows patients and medical practitioners to gain consistent and accurate data on a patient's COPD severity using simple spirometry.
- FEV1 Percentage of Predicted
- BMI (four levels)
- COPD severity (in accordance with recognised worldwide guidelines)
- Smoking Pack Years (cigarettes, cigars, rolling tobacco, cigarillos, pipes)
- DOSE Index Score
US and Metric systems incorporated throughout.
The FEV1 Percentage of Expected/Predicted calculator is designed to allow a basic spirometer to give COPD severity unique to the patient. This is based on established worldwide guidelines.
The PYcalc is a Pack Year Calculator that offers a calculation for smokers tobacco consumption based on more than just cigarettes. This will accept cigarettes, cigars, cigarillos, pipes and rolling tobacco. Pack Year calculations are vital to clinicians who have COPD patients that currently smoke.
The DOSE index calculator is a new system that can be used beside or instead of the Bode. This score is a number from 0 (good) to 8 (bad) which indicates how many resources a COPD patient is likely to require. This index has been used across the world in many practices and hospitals as a guideline to assist doctors and nurses in identifying which patients are likely to require more services and assistance as their disease progresses.
The COPDfastÂ® Suite (of which this is a part) is a unique set of tools that have been used across the world since they were created in 2005. It offers a consistent and accurate monitoring of COPD for patients anywhere and the calculators do not need access to the Internet to operate.
None of the calculators retain patient-identifable data and can be used anywhere at any time.
As with all software, these should never be regarded as diagnostic tools and are only designed to offer guidance and assistance to medical professionals and those specialists in respiratory care. Patients using these systems do so entirely at their own risk and all data gained from their use should be verified by medically qualified personnel.
March 17, 2013 Price Decrease: $2.99 -> $0.99
February 14, 2013 Initial Release